Oliver Helms Miller, PhD

Oliver Helms Miller, PhD has worked in a variety of roles since 2008. Oliver Helms began their career as a Research Assistant in the Endocrinology/Immunology Lab of Dr. Dale Leitman, MD PhD at the University of California, San Francisco. In 2010, they became a Louisiana Board of Regents Graduate Research Fellow at Tulane University, where they investigated the molecular, cellular, and circuit-level etiology underlying depression, and the antidepressant effects of ketamine. From 2014-2017, they were a Postdoctoral Researcher at Roche, where they led a team including data scientists and bioinformaticians to define how the "translatome" in medial prefrontal cortex is altered by treatment with antidepressants. In 2017, they became a NIH NRSA F32 Postdoctoral Fellow at the University of California, San Francisco. Since 2019, they have held roles as Senior Scientist - Translational Neuroscience and Scientist II - Translational Neuroscience at Inscopix, Inc. and Scientist II - Gene Therapy at Circuit Therapeutics.

Oliver Helms Miller holds a PhD from Tulane University, which they obtained in 2016 after studying Neuroscience. Prior to that, they obtained a Bachelors in Molecular, Cellular, and Developmental Biology; Neuroscience from the University of California, Santa Cruz in 2009. Miller is currently an NIH NRSA Postdoctoral Fellow at the University of California, San Francisco, a position they have held since 2017.